Form 8-K - Current report:
SEC Accession No. 0001628280-22-005708
Filing Date
2022-03-10
Accepted
2022-03-10 16:07:36
Documents
15
Period of Report
2022-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K toi-20220310.htm   iXBRL 8-K 40337
2 EX-99.1 item991-2021earningsand202.htm EX-99.1 264081
7 GRAPHIC image_0a.jpg GRAPHIC 14770
  Complete submission text file 0001628280-22-005708.txt   531737

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT toi-20220310.xsd EX-101.SCH 2316
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT toi-20220310_def.xml EX-101.DEF 16053
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT toi-20220310_lab.xml EX-101.LAB 30835
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT toi-20220310_pre.xml EX-101.PRE 16736
9 EXTRACTED XBRL INSTANCE DOCUMENT toi-20220310_htm.xml XML 14855
Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Filer) CIK: 0001799191 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39248 | Film No.: 22729115
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine